Biotech Intuition

SOZO Intution
  • 0.0 (0)
  • Life Sciences

Biotech Intuition helps you understand the biotechnology developments that matter—without the noise. Each concise episode highlights the day’s most consequential clinical results, regulatory decisions, scientific advances, partnerships, financings, and industry developments. We explain what happened, why it matters, the important uncertainties, and what to watch next. Produced by SOZO Intuition, the biotechnology intelligence platform connecting companies, therapeutics, technologies, diseases, research, and industry news. Episodes are AI-narrated and reviewed against original sources. Sources and further reading are included in the show notes.

Episodes

  1. 1d ago

    Biotech Daily - 15th October 2026

    This digest covers key developments from AstraZeneca, insitro, Takeda, Krystal Biotech, Labcorp Holdings and OMass Therapeutics, including a billion-dollar AI target-discovery collaboration, the first orexin agonist launch for narcolepsy type 1, positive early dermatology clinical data in Gorlin syndrome, a $722 million diagnostics asset acquisition, an FDA-accepted NDA resubmission and a $310 million Series C, alongside broader coverage across the sector.  This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 15th October 2026

  2. 2d ago

    Biotech Daily - 14th October 2026

    This digest covers key developments from Zealand Pharma, Arrowhead Pharmaceuticals, Pharming, Galderma, and Alentis Therapeutics, including a billion-dollar AI-designed protein collaboration, first-in-human tau knockdown data, a positive Phase II immunology readout, and a $1.5 billion dermatology acquisition, alongside broader coverage across the sector.  This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 14th October 2026

  3. 3d ago

    Biotech Daily - 13th October 2026

    This digest covers key developments from BioNTech, Samsung Biologics, Johnson & Johnson, and Formycon, including Phase III readouts, a cross-border tender offer, and regulatory acceptances, alongside broader coverage across the sector.  This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 13th October 2026

  4. Oct 9

    Biotech Daily - 9th October 2026

    Featuring Bristol Myers Squibb, Roche, Viatris and Pacira Pharmaceuticals Primary themes: Phase 3 clinical readouts, first-in-setting FDA approvals, and a non-opioid pain acquisition. This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 9th October 2026

  5. Oct 8

    Biotech Daily - 8th October 2026

    Featuring Pfizer, Addex Therapeutics, Neurosterix and Microba Life Sciences Primary themes: FDA regulatory approval, clinical product advancement, diagnostic product launch. This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 8th October 2026

  6. Oct 7

    Biotech Daily - 7th October 2026

    Featuring Capricor Therapeutics, Caribou Biosciences, Repligen and Arrowhead Pharmaceuticals. Primary themes: clinical trial results, business development and venture financing. This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 7th October 2026

  7. Oct 6

    Biotech Daily - 6th October 2026

    This digest covers key developments from Vaxcyte, AbbVie, Genmab, AstraZeneca, Summit Therapeutics and Eli Lilly, spanning pivotal Phase 3 readouts, a large equity transaction and regulatory and business-development updates across the sector. This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 6th October 2026

  8. Oct 5

    Biotech Daily - 5th October 2026

    This digest covers key developments from Shionogi, Alector and Eli Lilly, including corporate acquisitions, a Parkinson’s disease licensing deal and a first-line label expansion, alongside broader coverage across the sector. This brief was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 5th October 2026

  9. Oct 2

    Biotech Daily - 2nd October 2026

    Key developments from Johnson & Johnson, Ultragenyx, Abogen Biosciences, and Daiichi Sankyo.

    Biotech Daily - 2nd October 2026

  10. Oct 1

    Biotech Daily - 1st October 2026

    This audio brief covers key developments from Boehringer Ingelheim, Roche, Fresenius and Sanofi, including clinical trial readouts, regulatory and product advancements, and corporate acquisitions. It was generated using the SOZO Intuition platform, providing personalized biotech intelligence and catalyst tracking to help life sciences leaders make better decisions.

    Biotech Daily - 1st October 2026

  11. Sep 30

    Biotech Daily - September 30, 2026

    Full articles and references can be found: https://bobbyjim.substack.com/p/2026-09-30-biotech-daily-top-stories . Visit sozointuition.com for personalized biotechnology news and insights.

    Biotech Daily - September 30, 2026
  • 11 Episodes

About

Biotech Intuition helps you understand the biotechnology developments that matter—without the noise. Each concise episode highlights the day’s most consequential clinical results, regulatory decisions, scientific advances, partnerships, financings, and industry developments. We explain what happened, why it matters, the important uncertainties, and what to watch next. Produced by SOZO Intuition, the biotechnology intelligence platform connecting companies, therapeutics, technologies, diseases, research, and industry news. Episodes are AI-narrated and reviewed against original sources. Sources and further reading are included in the show notes.

Information

  • Creator
    SOZO Intution
  • Years Active
    2026
  • Episodes
    11
  • Rating
    Clean
  • Copyright
    © 2026 SOZO Intuition Systems, Corp.